Nanomedicine has shown good potentials for cancer diagnosis and treatment since the last decades. Among the various nanoparticles exploited for cancer management so far, gold nanomaterials(e.g., spherical gold nanopar...Nanomedicine has shown good potentials for cancer diagnosis and treatment since the last decades. Among the various nanoparticles exploited for cancer management so far, gold nanomaterials(e.g., spherical gold nanoparticles and gold nanorods)were extensively investigated due to their unique chemo-physical properties. We herein summarize the emerging application and discuss the challenges of using gold nanomaterials for therapy of metastatic cancer.展开更多
Efficient tumor-targeting drug delivery systems are urgently needed for treating metastatic breast cancer.In this work, a docetaxel(DTX)-loaded micelle(pDM) as the tumor-microenvironment-responsive delivery platform i...Efficient tumor-targeting drug delivery systems are urgently needed for treating metastatic breast cancer.In this work, a docetaxel(DTX)-loaded micelle(pDM) as the tumor-microenvironment-responsive delivery platform is developed. The micelle is composed of a pH-sensitive amphiphilic copolymer,poly((1,4-butanediol)-diacrylate-b-N,N-diisopropylethylenediamine)-polyethyleneimine(BD-PEI), and a matrix metalloproteinase(MMP)-responsive polymer, poly((1,4-butanediol)-diacrylate-b-N,N-diisopropy lethylenediamine)-peptide-polyethylene glycol(PEG)(BD-peptide-PEG). The PEG block of BD-peptidePEG will be split by MMPs at the tumor microenvironment, which leads to the change of the surface charge and particle size of the micelle to more positive and smaller one. Owing to this transformation and enhanced permeability and retention(EPR) effect, pDM delivers more DTX into tumor tissues and is internalized more efficiently by tumor cells than the non-MMP-sensitive micelles in the 4 T1 tumorbearing mice model. In addition, DTX is released in acidic endo/lysosomes due to the dissociation of the micelle, triggered by the protonation of the hydrophobic block of BD-PEI. As a result, the DTX-loaded micelle inhibits primary tumor growth and pulmonary metastasis effectively. Thus, this pH/MMP-dual-sensitive drug delivery system, which simultaneously attains three keypoints: prolonged circulation time, directional and efficient uptake into tumor cells, and speedy intracellular drug release, is a promising strategy for metastatic breast cancer therapy.展开更多
基金supported by the National Basic Research Program of China (2013CB932704)the National Natural Science Foundation of China (81373359, 21305047)the Youth Innovation Promotion Association CAS (2014248)
文摘Nanomedicine has shown good potentials for cancer diagnosis and treatment since the last decades. Among the various nanoparticles exploited for cancer management so far, gold nanomaterials(e.g., spherical gold nanoparticles and gold nanorods)were extensively investigated due to their unique chemo-physical properties. We herein summarize the emerging application and discuss the challenges of using gold nanomaterials for therapy of metastatic cancer.
基金supported by the National Natural Science Foundation of China(81871471,81630052,81690265,and 81521005)Key Scientific Research Program of Chinese Academy of Sciences(QYZDJSSW-SMC020)the Youth Innovation Promotion Associ-ation of Chinese Academy of Sciences(2015226)
文摘Efficient tumor-targeting drug delivery systems are urgently needed for treating metastatic breast cancer.In this work, a docetaxel(DTX)-loaded micelle(pDM) as the tumor-microenvironment-responsive delivery platform is developed. The micelle is composed of a pH-sensitive amphiphilic copolymer,poly((1,4-butanediol)-diacrylate-b-N,N-diisopropylethylenediamine)-polyethyleneimine(BD-PEI), and a matrix metalloproteinase(MMP)-responsive polymer, poly((1,4-butanediol)-diacrylate-b-N,N-diisopropy lethylenediamine)-peptide-polyethylene glycol(PEG)(BD-peptide-PEG). The PEG block of BD-peptidePEG will be split by MMPs at the tumor microenvironment, which leads to the change of the surface charge and particle size of the micelle to more positive and smaller one. Owing to this transformation and enhanced permeability and retention(EPR) effect, pDM delivers more DTX into tumor tissues and is internalized more efficiently by tumor cells than the non-MMP-sensitive micelles in the 4 T1 tumorbearing mice model. In addition, DTX is released in acidic endo/lysosomes due to the dissociation of the micelle, triggered by the protonation of the hydrophobic block of BD-PEI. As a result, the DTX-loaded micelle inhibits primary tumor growth and pulmonary metastasis effectively. Thus, this pH/MMP-dual-sensitive drug delivery system, which simultaneously attains three keypoints: prolonged circulation time, directional and efficient uptake into tumor cells, and speedy intracellular drug release, is a promising strategy for metastatic breast cancer therapy.